BMY EBITDA Margin
Bristol Myers Squibb · EBITDA Margin

BMY EBITDA Margin
Latest reported34.19%period ending
BMY EBITDA Margin (21.54% → 34.19%)
Annual ebitda margin
High-resolution chart · PNG
BMY ebitda margin history
Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | EBITDA Margin |
|---|---|
| 31.6008% | |
| 6.559% | |
| 43.0298% | |
| 41.6409% | |
| 43.3718% | |
| 11.5927% | |
| 28.2157% | |
| 30.0873% | |
| 29.4378% | |
| 33.2733% | |
| 15.9239% | |
| 19.2141% | |
| 23.5154% | |
| 18.1772% | |
| 36.4997% | |
| 35.0185% | |
| 34.5225% | |
| 28.6547% | |
| 22.8447% | |
| 18.4939% | |
| 24.2932% | |
| 27.7245% | |
| 27.3859% | |
| 26.6902% | |
| 30.3043% | |
| 36.9565% | |
| 29.2602% | |
| 27.7893% | |
| 30.112% | |
| 29.6847% | |
| 29.5126% | |
| 29.6145% | |
| 23.7536% | |
| 20.2133% | |
| 26.9917% | |
| 25.5631% | |
| 13.9188% | |
| 22.8441% | |
| 21.5401% |